ABIVAX Société Anonyme (ABVX)

Nasdaq · Healthcare · Biotechnology
$73.20-9.24%As of 2026-11-22 · USD
Last session low $62.97Last session high $79.73
52-week low $62.7052-week high $148.83
Market cap
$6.41B
Sector
Healthcare

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)30.3In the neutral range (30 to 70)
MACD (12, 26, 9)-3.27Below its signal line (-2.45); histogram -0.82
Bollinger %B (20, 2)-30%Below the lower band (78.01 to 94.18)
SMA 2086.10Price is 15.0% below
SMA 5091.16Price is 19.7% below
SMA 200111.78Price is 34.5% below
ATR (20)6.54% of priceAverage true range per day
52-week position12%In the lower part of the 62.70 to 148.83 range

About ABIVAX Société Anonyme

ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases.

More in Biotechnology